Neuro Oncology Advances
-
Publication Venue For
- Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastases.. 4:vdac086. 2022
- Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma.. 4:vdac040. 2022
- Improved prediction of postoperative pediatric cerebellar mutism syndrome using an artificial neural network.. 4:vdac003. 2022
- Mitochondrial 1555 G>A variant as a potential risk factor for childhood glioblastoma. 4. 2022
- Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.. 4:vdac025. 2022
- Advances in the management of breast cancer brain metastases.. 3:v63-v74. 2021
- The microenvironment of brain metastases from solid tumors.. 3:v121-v132. 2021
- A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.. 3:vdaa146. 2021
- An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End Results Program.. 3:vdaa175. 2021
- Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma.. 3:vdab058. 2021
- Glioblastoma as an age-related neurological disorder in adults.. 3:vdab125. 2021
- Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data.. 3:vdab142. 2021
- The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment.. 3:vdab035. 2021
- Evaluation of neurapheresis therapy in vitro: a novel approach for the treatment of leptomeningeal metastases.. 2:vdaa052. 2020
- Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis.. 2:vdaa089. 2020
- Proteins inform survival-based differences in patients with glioblastoma.. 2:vdaa039. 2020
- Highlights of the inaugural ten - the launch of Neuro-Oncology Advances.. 1:vdz016. 2019
- Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort.. 1:vdz036. 2019
- Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers 2022
- The state of neuro-oncology during the COVID-19 pandemic: A worldwide assessment 2021